Trade Now

Capital at risk Advertisement
Share Name Share Symbol Market Type Share ISIN Share Description
Astrazeneca Plc LSE:AZN London Ordinary Share GB0009895292 ORD SHS $0.25
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  192.00 1.95% 10,030.00 10,038.00 10,042.00 10,048.00 9,726.00 9,734.00 2,452,039 16:35:06
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,668.9 -196.0 5.9 1,399.3 155,376

AstraZeneca Says Imfinzi Improved Pathologic Complete Response in Lung Cancer

30/06/2022 7:43am

Dow Jones News

Astrazeneca (LSE:AZN)
Historical Stock Chart

From Apr 2022 to Oct 2022

Click Here for more Astrazeneca Charts.

By Jaime Llinares Taboada


AstraZeneca PLC said Thursday that Imfinzi combined with chemotherapy significantly improved pathologic complete response in patients with resectable lung cancer.

The pharmaceutical company reported positive results from an interim analysis of Phase III trials, as the treatment also caused a significant improvement in major pathologic response.

The trial will continue as planned to assess the additional primary endpoint of event-free survival.


Write to Jaime Llinares Taboada at; @JaimeLlinaresT


(END) Dow Jones Newswires

June 30, 2022 02:28 ET (06:28 GMT)

Copyright (c) 2022 Dow Jones & Company, Inc.

1 Year Astrazeneca Chart

1 Year Astrazeneca Chart

1 Month Astrazeneca Chart

1 Month Astrazeneca Chart
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to ADVFN
Register Now

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V:gb D:20221007 19:17:00